NCT00646854 2019-03-01
ACT-1
University of Aarhus
Phase 3 Completed
Clinical Trials
4 trialsNCT00564512 2013-07-25
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
French Innovative Leukemia Organisation
Phase 3 Completed
NCT00725231 2012-05-07
A-CHOP-14
University of Göttingen
Phase 3 Unknown
NCT00226512 2011-04-08
To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
Hadassah Medical Organization
Phase 3 Withdrawn